Author: Brenda Marie Rivers|| Date Published: November 17, 2020
The Defense Health Agency is looking for potential sources of research and development services as part of the agency’s follow-on Omnibus IV Medical R&D contract, Bloomberg Government reported Monday.
BGOV estimates the potential 10-year recompete award to have a ceiling value of $500M to cover a range of contract activities including information technology support, administrative services, logistics services and medical support.
Omnibus IV will include task orders for research, regulatory and translational assistance to support DHA initiatives aimed at improving force health readiness and rehabilitation, DHA said in the draft request for proposals posted Friday on the beta SAM website.
The indefinite-delivery/indefinite-quantity contract, which will replace the current Navy Medicine Omnibus III contract issued in 2012, will have a five-year base period and a five-year extension option, according to the solicitation.
BGOV data shows that Booz Allen Hamilton (NYSE: BAH), the top awardee for the incumbent contract, accounts for $100M in obligations.
Work under the new award is slated to commence in July 2021 and take place in various locations within and outside the continental U.S.
DHA will accept responses to the draft RFP through Nov. 30.
The Naval Information Warfare Center Pacific is soliciting proposals for the development and fielding of intelligence, surveillance and reconnaissance systems…
The Department of War is accelerating its push into unmanned systems, moving beyond experimentation toward large-scale production, streamlined acquisition and…
BAE Systems has received a $117.7 million contract modification from the U.S. Navy to support depot-level modernization, maintenance and repair of USS…
Advanced wireless infrastructure is becoming as strategically important as artificial intelligence in modern defense operations 5G standalone enables network slicing,…
